Murilo Freitas – Page 25

FDA Proposes Rule to Require Standardized Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products

Murilo Freitas - 17:08, 25 de December de 2024216

FDA Proposes Rule to Require Standardized Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products
http://www.fda.gov/news-events/press-announcements/fda-proposes-rule-require-standardized-testing-methods-detecting-and-identifying-asbestos-talc

rss

Astellas Pharma US, Inc. Issues Voluntary Nationwide Recall of One Lot of PROGRAF® 0.5mg (Tacrolimus) and One Lot of ASTAGRAF XL® 0.5mg (Tacrolimus Extended-Release Capsules) Because Bottles Shipped to U.S. May Contain Empty Capsules

Murilo Freitas - 05:00, 23 de December de 2024245

Astellas Pharma US, Inc. (Head of US Commercial: Michael Petroutsas, “Astellas”) is voluntarily recalling one lot of PROGRAF® 0.5mg (tacrolimus) and one lot of ASTAGRAF XL® 0.5mg (tacrolimus extended-release) capsules to the consumer level. These products are being recalled because bottles may conta

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/astellas-pharma-us-inc-issues-voluntary-nationwide-recall-one-lot-prografr-05mg-tacrolimus-and-one

rss

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes

Murilo Freitas - 16:24, 22 de December de 2024240

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes
http://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-once-daily-glp-1-injection-lower-blood-sugar-patients-type-2-diabetes

rss

Alcon Laboratories Issues Voluntary Nationwide Recall of One (1) Lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count (Lot 10101), Due to Fungal Contamination

Murilo Freitas - 05:00, 22 de December de 2024223

Fort Worth, Texas. Alcon Laboratories is voluntarily recalling one (1) lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count (Lot 10101) to the consumer level. Alcon evaluated a consumer complaint of foreign material observed inside a sealed single use vial and determined th

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/alcon-laboratories-issues-voluntary-nationwide-recall-one-1-lot-systane-lubricant-eye-drops-ultra-pf

rss

Early Alert: Endoscope Accessories Forceps/Irrigation Plug Issue from Olympus

Murilo Freitas - 05:00, 22 de December de 2024163

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program

http://www.fda.gov/medical-devices/medical-device-recalls/early-alert-endoscope-accessories-forcepsirrigation-plug-issue-olympus

rss

FDA Approves First Medication for Obstructive Sleep Apnea

Murilo Freitas - 22:03, 19 de December de 2024288

FDA Approves First Medication for Obstructive Sleep Apnea
http://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea

rss

FDA Roundup: December 20, 2024

Murilo Freitas - 19:28, 19 de December de 2024173

FDA Roundup: December 20, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-20-2024

rss

FDA Approves First Acellular Tissue Engineered Vessel to Treat Vascular Trauma in Extremities

Murilo Freitas - 14:25, 19 de December de 2024182

FDA Approves First Acellular Tissue Engineered Vessel to Treat Vascular Trauma in Extremities
http://www.fda.gov/news-events/press-announcements/fda-approves-first-acellular-tissue-engineered-vessel-treat-vascular-trauma-extremities

rss

Early Alert: Nephroscope Sheath Issue from Trokamed GmbH

Murilo Freitas - 05:00, 19 de December de 2024169

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program

http://www.fda.gov/medical-devices/medical-device-recalls/early-alert-nephroscope-sheath-issue-trokamed-gmbh

rss

Endo USA, Inc. Issues Voluntary, Nationwide Recall of Adrenalin® Chloride Solution (EPINEPHrine Nasal Solution, USP) Due to the Potential for Administration Errors

Murilo Freitas - 05:00, 19 de December de 2024164

Endo, Inc (OTCQX: NDOI) (“Endo”), announced today that one of its operating subsidiaries, Endo USA, Inc., is voluntarily recalling all lots within expiry of Adrenalin® Chloride Solution (EPINEPHrine nasal solution, USP) 30mg/30mL (1mg/mL) 30 mL vials, to the consumer level. This product, which pre-d

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/endo-usa-inc-issues-voluntary-nationwide-recall-adrenalinr-chloride-solution-epinephrine-nasal